Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,463 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00591656 | Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer | unknown | — | 69 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00592059 | Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer | unknown | — | 77 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 |
| clinicaltrials |
| NCT00157560 | Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma | completed | Phase 2 | 83 | Massachusetts General HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00050375 | Clinical Trial for Ovarian Cancer (OvaRex®) | terminated | Phase 3 | 354 | Unither PharmaceuticalsINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00086632 | Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment | terminated | Phase 2 | 40 | Unither PharmaceuticalsINDUSTRY | 0 | Dec 18, 2007 | clinicaltrials |
| NCT00047632 | Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | terminated | Phase 3 | 847 | InterMuneINDUSTRY | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00533299 | Hydralazine Valproate for Ovarian Cancer | unknown | Phase 3 | 211 | National Institute of CancerologíaOTHER_GOV | 1 | Sep 21, 2007 | clinicaltrials |
| NCT00527631 | Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer(OVAR-IMRT-01) | unknown | Phase 1 | 8 | Heidelberg UniversityOTHER | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | completed | Phase 2 | 42 | National Cancer Institute, NaplesOTHER | 1 | Sep 5, 2007 | clinicaltrials |
| NCT00189579 | Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer | terminated | Phase 2 | 45 | ARCAGY/ GINECO GROUPOTHER | 1 | Aug 17, 2007 | clinicaltrials |
| NCT00155935 | The Development of Human Immunologic Assays Specific to Folate Receptor Antigen | unknown | N/A | 50 | National Taiwan University HospitalOTHER | 1 | Aug 13, 2007 | clinicaltrials |
| NCT00162721 | The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas | unknown | Phase 3 | 270 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00490711 | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer | completed | Phase 2 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00482300 | Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer | completed | N/A | — | University of Roma La SapienzaOTHER | 0 | Jun 5, 2007 | clinicaltrials |
| NCT00479375 | Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening(SWEDESCREEN) | completed | N/A | 12,527 | Skane University HospitalOTHER | 1 | May 28, 2007 | clinicaltrials |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment | completed | Phase 4 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2007 | clinicaltrials |
| NCT00463996 | MRI in Staging Ovarian Cancer Using MRI Contrast Agent | unknown | — | 50 | University of AarhusOTHER | 0 | Apr 20, 2007 | clinicaltrials |
| NCT00319462 | Localization of Point A in Cervical Cancer | unknown | N/A | 20 | Mackay Memorial HospitalOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | terminated | Phase 2 | 38 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00327925 | Blood Test for Ovarian Cancer Associated Antibodies (CAAb) | unknown | — | 60 | Lab Discoveries Ltd.INDUSTRY | 1 | Mar 2, 2007 | clinicaltrials |
| NCT00067249 | Women's Use of Alternative Medicine: A Multiethnic Study | completed | — | 3,200 | National Center for Complementary and Integrative Health (NCCIH)NIH | 0 | Feb 27, 2007 | clinicaltrials |
| NCT00287482 | Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. | terminated | N/A | 20 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Feb 12, 2007 | clinicaltrials |
| NCT00419627 | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas | unknown | — | 160 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Jan 8, 2007 | clinicaltrials |
| NCT00166985 | The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Dec 27, 2006 | clinicaltrials |
| NCT00154583 | Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions | unknown | — | 500 | National Taiwan University HospitalOTHER | 1 | Dec 21, 2006 | clinicaltrials |
| NCT00173394 | The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients | unknown | — | 250 | National Taiwan University HospitalOTHER | 1 | Dec 19, 2006 | clinicaltrials |
| NCT00154479 | The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus | unknown | — | 700 | National Taiwan University HospitalOTHER | 1 | Dec 14, 2006 | clinicaltrials |
| NCT00404326 | Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer | completed | Phase 2 | 18 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 28, 2006 | clinicaltrials |
| NCT00102414 | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer | completed | Phase 3 | 356 | AGO Study GroupOTHER | 0 | Nov 14, 2006 | clinicaltrials |
| NCT00163930 | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | unknown | — | — | Bayside HealthOTHER_GOV | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00103545 | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | completed | Phase 1 / Phase 2 | 36 | AGO Study GroupOTHER | 1 | Oct 2, 2006 | clinicaltrials |
| NCT00146458 | Usefulness of FDG-PET for Advanced Cervical Cancer | unknown | Phase 3 | 200 | Chang Gung Memorial HospitalOTHER | 1 | Sep 20, 2006 | clinicaltrials |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer | terminated | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Sep 15, 2006 | clinicaltrials |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | terminated | Phase 2 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00070967 | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer | completed | Phase 2 | 40 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00102375 | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer | completed | Phase 3 | 900 | AGO Study GroupOTHER | 1 | Aug 4, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00275353 | Effectiveness of an Individualized Symptom Education Program (ISEP) | completed | Phase 2 | 144 | University of TorontoOTHER | 1 | May 26, 2006 | clinicaltrials |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma | terminated | Phase 1 / Phase 2 | 60 | Celgene CorporationINDUSTRY | 1 | Apr 12, 2006 | clinicaltrials |
| NCT00312988 | Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | completed | Phase 3 | 450 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Apr 11, 2006 | clinicaltrials |
| NCT00199680 | Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer | unknown | Phase 2 | 42 | University Hospital, LimogesOTHER | 1 | Feb 1, 2006 | clinicaltrials |
| NCT00155766 | Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs) | unknown | Phase 1 | 12 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2005 | clinicaltrials |
| NCT00155792 | The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being | unknown | — | 300 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2005 | clinicaltrials |
| NCT00155740 | Mesothelin as a New Tumor Marker for Ovarian Cancer | unknown | — | 250 | National Taiwan University HospitalOTHER | 1 | Nov 28, 2005 | clinicaltrials |
| NCT00231075 | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV | completed | Phase 2 | 75 | ARCAGY/ GINECO GROUPOTHER | 1 | Nov 3, 2005 | clinicaltrials |
| NCT00155077 | The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer Patients | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Oct 20, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jan 11, 2008source: clinicaltrials